New insights into type I interferon and the immunopathogenesis of persistent viral infections

被引:38
|
作者
Snell, Laura M. [1 ,2 ]
Brooks, David G. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA
[3] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada
[4] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada
基金
美国国家卫生研究院;
关键词
CHRONIC HEPATITIS-C; CD8; T-CELLS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PLASMACYTOID DENDRITIC CELLS; FOLLICULAR HELPER; IMMUNE ACTIVATION; CLONAL EXPANSION; HIV; EXPRESSION; RESPONSES;
D O I
10.1016/j.coi.2015.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most viruses generate potent T cell responses that rapidly control infection. However, certain viruses can subvert the immune response to establish persistent infections. The inability to clear virus induces an immunosuppressive program leading to the sustained expression of many immunoregulatory molecules that down-regulate T cell responses. Further, viral persistence is associated with multiple immune dysfunctions including lymphoid disorganization, defective antigen presentation, aberrant B cell responses and hypergammaglobulinemia. Although best known for its antiviral activity, recent data has highlighted the role of type I IFN (IFN-I) signaling as a central mediator of immunosuppression during viral persistence. It is also becoming increasingly apparent that many of the immune dysfunctions during persistent virus infection can be attributed directly or indirectly to the effects of chronic IFN-I signaling. This review explores the increasingly complex role of IFN-I in the regulation of immunity against persistently replicating virus infections and examines current and potential uses of IFN-I and blockade of IFN-I signaling to dampen chronic inflammation and activation in the clinic.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [31] Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome
    Scagnolari, Carolina
    Antonelli, Guido
    CYTOKINE & GROWTH FACTOR REVIEWS, 2018, 40 : 19 - 31
  • [32] PERSISTENT VIRAL-INFECTIONS
    不详
    PUBLIC HEALTH REPORTS, 1962, 77 (01) : 71 - 73
  • [33] New insights into IDO biology in bacterial and viral infections
    Schmidt, Susanne V.
    Schultze, Joachim L.
    FRONTIERS IN IMMUNOLOGY, 2014, 5 : 1 - 12
  • [34] IMMUNOSUPPRESSION, INTERFERON, AND VIRAL INFECTIONS
    GLASGOW, LA
    FEDERATION PROCEEDINGS, 1971, 30 (06) : 1846 - &
  • [35] Cytokines and persistent viral infections
    Beltra, Jean-Christophe
    Decaluwe, Helene
    CYTOKINE, 2016, 82 : 4 - 15
  • [36] Interferon type I responses in primary and secondary infections
    Alsharifi, Mohammed
    Muellbacher, Arno
    Regner, Matthias
    IMMUNOLOGY AND CELL BIOLOGY, 2008, 86 (03): : 239 - 245
  • [37] Persistent Virus Infection Inhibits Type I Interferon Production by Plasmacytoid Dendritic Cells to Facilitate Opportunistic Infections
    Zuniga, Elina I.
    Liou, Li-Ying
    Mack, Lauren
    Mendoza, Marilyn
    Oldstone, Michael B. A.
    CELL HOST & MICROBE, 2008, 4 (04) : 374 - 386
  • [38] INTERFERON IN THE TREATMENT OF PERSISTENT VIRAL WARTS
    GIBSON, JR
    HARVEY, SG
    DERMATOLOGICA, 1984, 169 (01): : 47 - 48
  • [39] INTERFERON IN THE TREATMENT OF PERSISTENT VIRAL WARTS
    GIBSON, JR
    HARVEY, SG
    BRITISH JOURNAL OF DERMATOLOGY, 1983, 109 (06) : 694 - 695
  • [40] The role of type I interferon in persistent murine norovirus infection
    Blacklaws, B.
    Chettle, J.
    Shortland, A.
    Zaccone, P.
    Newland, S.
    Gibbs, S.
    Tonks, P.
    Man, S.
    Tourlomousis, P.
    Cooke, A.
    Bryant, C.
    Heeney, J.
    IMMUNOLOGY, 2012, 137 : 646 - 646